clnow Biotechnology

CLnow Biotechnology is a pioneering biotechnology company based in Suzhou, China, focused on the development of innovative cell therapies through its proprietary Cell-in-Cell (CIC) technology platform. The company specializes in the biological phenomenon where one living cell is internalized by another, a process known as entosis, to create novel therapeutic structures for treating solid tumors. By engineering these Cell-in-Cell interactions, CLnow aims to enhance the targeting and destruction of cancer cells within the tumor microenvironment. Led by founder Dr. Qiang Sun, the company is advancing a pipeline of pre-clinical programs that leverage cell-cell competition and interaction as a new modality in oncology. CLnow is recognized as one of the first biotech firms globally to focus on the industrial application of CIC biology for drug discovery.